Rectal Dose-Volume Parameters and a Source Strength of Ir-192 are Significant Independent Predictors of Late Rectal Morbidity in Patients with Computed Tomography-Based Image-Guided Brachytherapy for Cervical Cancer

被引：0
|
作者：
Isohashi, F. [1 ]
Otani, K. [1 ]
Tamari, K. [1 ]
Seo, Y. [1 ]
Suzuki, O. [1 ]
Mabuchi, S. [2 ]
Kimura, T. [2 ]
Ogawa, K. [1 ]
机构：
[1] Osaka Univ, Grad Sch Med, Dept Radiat Oncol, Suita, Osaka, Japan
[2] Osaka Univ, Grad Sch Med, Dept Obstet & Gynecol, Suita, Osaka, Japan
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2018年 / 102卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2018.07.1708
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TU_14_3462
引用
收藏
页码：E625 / E625
页数：1
相关论文
共 33 条
  • [31] Preliminary experience on the implementation of computed tomography (CT)-based image guided brachytherapy (IGBT) of cervical cancer using high-dose-rate (HDR) Cobalt-60 source in University of Malaya Medical Centre (UMMC)
    Jamalludin, Z.
    Min, U. N.
    Ishak, W. Z. Wan
    Malik, R. Abdul
    13TH SOUTH-EAST ASIAN CONGRESS OF MEDICAL PHYSICS 2015 (SEACOMP), 2016, 694
  • [32] A Comparison of Magnetic Resonance and Computed Tomography Imaging Based Target-Volume Definition and Interfraction Variations of Treatment Planning Parameters (D90 HR-CTV, D2cc for OARs) During Image Guided Adaptive Brachytherapy for Cervical Cancer
    Kizilkaya, Hazim Orhan
    Dogan, Ayse Kutluhan
    Dag, Zedef
    Turan, Halime Can
    Aksan, Donay Unluer
    Arslan, Nazmiye Deniz
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2019, 29 (04): : 227 - 237
  • [33] Variation of treatment planning parameters (D90 HR-CTV, D2cc for OAR) for cervical cancer tandem ring brachytherapy in a multicentre setting: Comparison of standard planning and 3D image guided optimisation based on a joint protocol for dose-volume constraints
    Jurgenliemk-Schulz, Ina M.
    Lang, Stefan
    Tanderup, Kari
    de Leeuw, Astrid
    Kirisits, Christian
    Lindegaard, Jacob
    Petric, Primoz
    Hudej, Robert
    Poetter, Richard
    RADIOTHERAPY AND ONCOLOGY, 2010, 94 (03) : 339 - 345
1234